PHARMACOGENOMIC IMPLICATIONS OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITION IN ST-ELEVATION MYOCARDIAL INFARCTION

Authors :: Nicole Cristell
Giovanni Peretto
Marco Magnoni
Domenico Cianflone
Paolo Manunta
Lorena Citterio
Sara Baggio
Chiara Lanzani
Peretto, G
Baggio, S
Magnoni, M
Cristell, N
Lanzani, C
Citterio, L
Manunta, P
Cianflone, D
Source :: Journal of the American College of Cardiology. 69:12
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.
Abstract: Background: A complex network of gene-environment interactions may be related to myocardial infarction. To date, several single nucleotide polymorphisms (SNPs) have been investigated as potential determinants in terms of predisposition, prognosis and response to therapy, but with no definite

Subjects :: medicine.medical_specialty
Angiotensin II receptor type 1
Response to therapy
business.industry
Single-nucleotide polymorphism
030204 cardiovascular system & hematology
medicine.disease
030218 nuclear medicine & medical imaging
03 medical and health sciences
0302 clinical medicine
St elevation myocardial infarction
Internal medicine
Pharmacogenomics
Renin–angiotensin system
medicine
Cardiology
Myocardial infarction
Cardiology and Cardiovascular Medicine
business

Full Text Access

Tools